Projects per year
Search results
-
Active
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneic hematopoietic cell transplantation
Betts, B. (PI), Holtan, S. G. (CoI) & Linden, M. A. (CoI)
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
4/1/23 → 2/29/28
Project: Research project
-
PTCy + Sirolimus/VIC-1911 as GVHD prophylaxis in myeloablative PBSC transplantation
Grover, P. (PI) & Holtan, S. G. (Prior Principal Investigator)
8/20/21 → 8/31/26
Project: Research project
-
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids for Treatment of Minnesota High-Risk Acute GVHD (aGVHD): A Phase I/II Study
Grover, P. (PI) & Holtan, S. G. (Prior Principal Investigator)
6/1/21 → 5/31/26
Project: Research project
-
AGAVE-201, A Phase 2, Open-label, Randomized, MulticenterStudy to Evaluate the Efficacy, Safety and Tolerability ofAxatilimab at 3 Different Doses in Patients with Recurrent orRefractory Active Chronic Graft Versus Host Disease who haveReceived at le
Holtan, S. G. (PI) & Arora, M. (Prior Principal Investigator)
11/1/20 → 10/31/25
Project: Research project
-
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Kratzke, R. A. (PI), Domingo-Musibay, E. (Prior Principal Investigator) & Holtan, S. G. (Prior Principal Investigator)
BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB COMPANY
12/1/17 → 3/31/25
Project: Research project
-
Finished
-
MT2018-36 INSPIRE: A Multicenter Randomized Controlled Trial integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation
Holtan, S. G. (PI)
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
5/1/20 → 11/30/21
Project: Research project
-
MT2018-36 INSPIRE: A Multicenter Randomized Controlled Trial integrating health informatics in a scalablestepped care self-management program for survivors after hematopoietic cell transplantation
Holtan, S. G. (PI)
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
5/1/19 → 4/30/20
Project: Research project
-
Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation (CHARM)
Holtan, S. G. (PI), Arora, M. (Prior Principal Investigator), Brunstein, C. G. (Prior Principal Investigator) & Weisdorf, D. J. (Prior Principal Investigator)
NATIONAL MARROW DONOR PROGRAM, NATIONAL INSTITUTES OF HEALTH (NIH)
4/10/19 → 4/30/24
Project: Research project
-
Holtan GVHD National Advisory Board consulting agreement
Holtan, S. G. (PI)
9/5/18 → 9/4/19
Project: Research project
-
A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of SNDX-6352 in Subjects with Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Prior Therapy, i
Holtan, S. G. (PI) & Arora, M. (Prior Principal Investigator)
9/1/18 → 2/28/24
Project: Research project
-
Neoadjuvant therapy for patients with high risk stage III melanoma
Kratzke, R. A. (PI), Domingo-Musibay, E. (Prior Principal Investigator) & Holtan, S. G. (Prior Principal Investigator)
MAYO CLINIC ROCHESTER, AMERICAN ASSOCIATION FOR CANCER RESEARCH
6/1/18 → 11/30/24
Project: Research project
-
A Phase I Study of Neihulizumab (AbGn-168H) in Patients
Holtan, S. G. (PI)
3/1/18 → 3/1/24
Project: Research project
-
-
Clinical Presentation, Treatment, and Outcome
Holtan, S. G. (PI)
11/13/17 → 2/28/21
Project: Research project
-
CITN-06:A Phase 1 Study of the Clinical and Immunologic
Holtan, S. G. (PI)
FRED HUTCHINSON CANCER CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)
9/21/17 → 8/31/19
Project: Research project
-
ALT-803 (IL-15/IL-15Ra-Fc) maintenance after allogeneic
Holtan, S. G. (PI), Arora, M. (CoI), Wagner, J. E. (CoI), Brunstein, C. G. (Prior Principal Investigator) & Weisdorf, D. J. (Prior Principal Investigator)
NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
7/26/17 → 6/30/24
Project: Research project
-
A Phase 1 Study of the Clinical and Immunologic
Holtan, S. G. (PI)
FRED HUTCHINSON CANCER CENTER, ALTOR BIOSCIENCE LLC
7/1/16 → 12/31/19
Project: Research project
-
CITN-06:A Phase 1 Study of the Clinical and Immunologic
Holtan, S. G. (PI)
FRED HUTCHINSON CANCER CENTER, MELANOMA RESEARCH ALLIANCE
9/1/15 → 12/30/18
Project: Research project
-
CITN-06:A Phase 1 Study of the Clinical and Immunologic
Holtan, S. G. (PI)
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
9/1/15 → 8/31/17
Project: Research project
-
13 SCP - Randomized Study of Individualized Care Plans f
Holtan, S. G. (PI)
NATIONAL MARROW DONOR PROGRAM, PATIENT-CENTERED OUTCOMES RESEARCH INST.
6/24/15 → 12/31/16
Project: Research project
-
A Multi-center Phase II Trial Randomized Novel Approache
Holtan, S. G. (PI)
3/6/15 → 2/25/18
Project: Research project
-
Inflammation, endothelial damage, and angiogenesis
Holtan, S. G. (PI)
1/20/15 → 12/31/15
Project: Research project
-
A Phase 2A study of ALXN1007 in subjects with newly diag
Holtan, S. G. (PI)
3/4/14 → 3/30/18
Project: Research project
-
A Multicenter Double-blind Placebo-controlled Adaptive P
Holtan, S. G. (PI)
1/1/12 → 12/31/21
Project: Research project
-
PROCLAIM: Proleukin Obervational Registry to Evaluate
Holtan, S. G. (PI), Dudek, A. Z. (Prior Principal Investigator) & Rudrapatna, V. K. (Prior Principal Investigator)
10/1/11 → 12/31/19
Project: Research project